Medicine and Dentistry
Inpatient
100%
Patient
92%
Cohort Analysis
80%
Patient with Inflammatory Bowel Disease
64%
COVID-19
40%
Diagnosis
31%
Biological Product
30%
Biological Therapy
29%
Disease Course
27%
Crohn's Disease
23%
Therapeutic Procedure
23%
Hospital
21%
Health
20%
Infection
20%
Outpatient
20%
Neonates
20%
Developmental Milestone
20%
Patient Care
20%
Prospective Cohort Study
20%
Patient Registry
20%
Obstructive Lung Disease
20%
Saquinavir
20%
Human Immunodeficiency Virus
20%
Antiretroviral Therapy
20%
Retrospective Cohort Study
20%
Colorectal Cancer
20%
Infliximab
20%
Pharmacokinetics
20%
Premedication
20%
Tuberculosis
20%
Adult
20%
Inflammatory Disorder
15%
Lamivudine/Zidovudine
11%
Odds Ratio
11%
Patient with Ulcerative Colitis
10%
Biological Marker
10%
Patient with Crohn's Disease
9%
Infant
9%
Diseases
9%
Follow up
9%
Ulcerative Colitis
8%
Bland-Altman Plot
8%
Consultation
8%
Kappa Statistics
8%
Antibody
7%
Observational Study
6%
Medical Record
6%
Childbirth
5%
Interferon Gamma Release Assay
5%
Physician
5%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammatory Bowel Disease
63%
Cohort Study
60%
HIV
40%
Diseases
29%
Chronic Obstructive Lung Disease
20%
Monotherapy
20%
Randomized Controlled Trial
20%
Inflammatory Disease
15%
Retrospective Study
6%
Elimination
5%